創新與跨域 細胞與基因治療新趨勢

2021亞洲生技大會（BIO Asia-Taiwan 2021）」於7/21∼7/25舉行，今年大會主題為「疫情中生技產業再出發（A Brave New Era for Biotechnology）」，展望疫後生醫新趨勢與機會，論壇鎖定從全球抗疫、先進療法、精準醫療、數位醫療、及投資與區域合作等五大重要領域。本會將與生技中心共同合辦7/23（五）「創新與跨域細胞與基因治療新趨勢」論壇。會中特別邀請諾華、美國德州大學MD安德森癌症中心、Peter MacCallum Cancer Centre、IQVIA、醫藥品查驗中心、生技中心等國內外講者就細胞治療生態圈、法規、臨床試驗等探討細胞與基因治療未來發展。另也邀請北醫、史丹佛大學Biodesign Program、MedVenture Partners等專家分享如何透過Biodesign計劃建構生醫創業與產業合作生態系。

本次分論壇特別提供給本會前50名報名之會員可免費參與，歡迎會此議題有興趣的會員，儘速報名。謝謝

活動報名連結：https://forms.gle/tkU4VfT79wBGzhAn6

台灣玉山科技協會秘書處

敬邀

如以下資訊未能顯示，請見附檔

Cell and gene therapies to date have demonstrated promising potential against certain cancers and hereditary diseases, and are poised to lead the healthcare shift into precision medicine over the next decade.

Join us atBIO Asia–Taiwan 2021to understand current developments, the growing cell and gene therapy ecosystem, regulatory conditions, and how to set up clinical trials for cell and gene therapies in Asia. Another segment to watch is biodesign for medical devices, where collaborations with international medical device partners—such as theStanford Biodesign program—are changing the landscape of medical device innovation in Asia.

Register now to gain in-depth insight in these two cutting-edge fields at BIO Asia–Taiwan 2021!

Hear from Experts

Session 11 – Advances in Cell & Gene Therapies

Distinguished Speakers

Hear from Experts

Session 13 –Asian Biodesign- Accelerating to Meet the Medical Needs

Distinguished Speakers